![Mineralys Therapeutics Inc](/common/images/company/N_MLYS.png)
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase in... Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.06 | -0.582524271845 | 10.3 | 11.09 | 9.015 | 320224 | 10.02802751 | CS |
4 | 0.66 | 6.88935281837 | 9.58 | 11.09 | 9.015 | 257707 | 10.03975715 | CS |
12 | -1.75 | -14.5954962469 | 11.99 | 14.19 | 8.6 | 224996 | 11.18287738 | CS |
26 | -0.92 | -8.24372759857 | 11.16 | 15.25 | 8.58 | 199501 | 11.87194784 | CS |
52 | -4.23 | -29.2328956462 | 14.47 | 16.905 | 8.58 | 188621 | 12.40545194 | CS |
156 | -10.86 | -51.4691943128 | 21.1 | 21.98 | 5.85 | 191412 | 12.67959511 | CS |
260 | -10.86 | -51.4691943128 | 21.1 | 21.98 | 5.85 | 191412 | 12.67959511 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관